← Back to Search

Other

Remote Ischemic Conditioning for Urological Diseases

N/A
Waitlist Available
Led By Baburao Koneru, MD, MPH
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days
Awards & highlights

Study Summary

This phase II randomized (1:1) controlled trial will examine the effects of remote ischemic conditioning (RIC) on the outcomes of major abdominal surgery. One hundred subjects will be enrolled at a single institution - University Hospital - Newark. The study population are patients undergoing major abdominal surgery (anticipated to be >/= 2 hrs long with a hospital stay >/= 2 days). Subjects in the treatment group will receive lower limb ischemic conditioning at 3 different time points: before surgery, POD 1 and POD 2. The primary outcome is the 30-day comprehensive complications index (CCI). Key secondary outcomes are changes in systemic inflammatory markers in peripheral blood and 30-day mortality.

Eligible Conditions
  • Retroperitoneal Disease
  • Urological Diseases
  • Complications of Surgery
  • Gastrointestinal Disease
  • Pancreatic Disease
  • Pelvic Disease
  • Liver Disease
  • Laparotomy
  • Laparoscopy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comprehensive Complication Index
Secondary outcome measures
30-day mortality
Completion all three interventions
Hospital days
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Remote Ischemic ConditioningExperimental Treatment1 Intervention
The RIC intervention consists of 5 minutes of inflation of a pneumatic tourniquet placed mid-thigh followed by 5 minutes of deflation, repeated for 3 cycles. The pressure used will be 250 mmHg for the pre-operative intervention. Subsequent tourniquet pressures will be 50 mmHg above the patient's systolic blood pressure.
Group II: No Remote Ischemic ConditioningPlacebo Group1 Intervention
The No RIC group will receive a sham intervention at all the same time points. The thigh tourniquet will be inflated to only 20 mmHg (to mask the intervention from the subject).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Remote ischemic conditioning
2017
Completed Phase 2
~7250

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,132 Total Patients Enrolled
Baburao Koneru, MD, MPHPrincipal InvestigatorRutgers-NJMS
1 Previous Clinical Trials
31 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~13 spots leftby Apr 2025